EPISODE · Dec 14, 2022 · 30 MIN
Marijuana—Worse Than We Thought? The Benefits (And Risks) Of Weight-Loss Drugs
from ACSH Science Dispatch · host ACSH
A recent study found that marijuana smoke may cause emphysema. The problem? The study was complete garbage. Celebrities and social-media "influencers" are hyping the weight-loss benefits of repurposed diabetes drugs. Should these medicines really be used to slim down? It's complicated. Join host Cameron English as he sits down Dr. Chuck Dinerstein to break down these stories on episode 29 of the Science Dispatch podcast: Another Health Harm from Marijuana “In a new analysis of medical records, cannabis smokers had higher rates of a certain type of emphysema than tobacco smokers.” It's another attention-grabbing headline that fails to tell the whole story. Let’s skip the public relations version and consider the study's findings. Ozempic Goes Way Off-Label Ozempic, a drug indicated for Type 2 diabetes, has become the latest weight-loss darling. Not since ivermectin has a drug gained so much interest from its off-label uses. Let’s take a deeper look at the science and a regulatory conundrum.
Embed this episode
NOW PLAYING
Marijuana—Worse Than We Thought? The Benefits (And Risks) Of Weight-Loss Drugs
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.